🇺🇸 FDA
Patent

US 8946233

Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

granted A61PA61P43/00A61P9/04

Quick answer

US patent 8946233 (Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents) held by Theravance Biopharma R&D IP, LLC expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P43/00, A61P9/04, A61P9/12